Table of Contents
इक्विटी फंड वे हैं जिनके संचित फंड का पैसा विभिन्न कंपनियों के इक्विटी और इक्विटी से संबंधित उपकरणों में निवेश किया जाता है। मध्यम और उच्च स्तर वाले लोगों के लिए इक्विटी फंड को दीर्घकालिक निवेश विकल्प माना जाता है।जोखिम उठाने का माद्दा. इक्विटी फंड की विभिन्न श्रेणियों में शामिल हैंलार्ज कैप फंड,मिड कैप फंड,स्मॉल कैप फंड,ईएलएसएस, और इसी तरह। वर्ष 2021 में, इक्विटी बाजारों में तेजी देखी गई, जिसके कारण अधिकांश इक्विटी फंड श्रेणियों ने अच्छा प्रदर्शन किया है। इन फंडों का प्रदर्शन बहुत सारे मैक्रो और माइक्रोइकॉनॉमिक मापदंडों पर निर्भर करता है जैसे कि उद्योग का प्रदर्शन, कंपनी का प्रदर्शन, कंपनियों की कमाई और मुनाफा, इसकी भविष्य की संभावनाएं, और इसी तरह। शीर्ष औरसर्वश्रेष्ठ इक्विटी फंड वर्ष 2021 के लिए इस प्रकार हैं।
Talk to our investment specialist
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹104.651
↑ 0.01 ₹30,401 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹50.7897
↑ 0.01 ₹1,005 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹53.3884
↓ -0.05 ₹4,360 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹63.4987
↓ -0.04 ₹13,023 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹181.14
↓ -0.14 ₹6,641 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹284.954
↓ -1.14 ₹1,062 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹432.453
↑ 4.56 ₹3,689 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.0908
↓ -0.11 ₹1,232 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹30.585
↑ 0.00 ₹576 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹395.818
↓ -0.11 ₹11,470 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 1 Jul 25
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized
return of 23% since its launch. Ranked 27 in Mid Cap
category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (01 Jul 25) ₹104.651 ↑ 0.01 (0.01 %) Net Assets (Cr) ₹30,401 on 31 May 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.56 Information Ratio 0.47 Alpha Ratio 9.44 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,285 30 Jun 22 ₹19,393 30 Jun 23 ₹26,738 30 Jun 24 ₹43,870 30 Jun 25 ₹48,048 Returns for Motilal Oswal Midcap 30 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 5% 3 Month 14.6% 6 Month -7.2% 1 Year 8.9% 3 Year 35.4% 5 Year 36.9% 10 Year 15 Year Since launch 23% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.67 Yr. Niket Shah 1 Jul 20 4.92 Yr. Rakesh Shetty 22 Nov 22 2.53 Yr. Sunil Sawant 1 Jul 24 0.92 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 May 25
Equity Sector Allocation
Sector Value Technology 29.87% Consumer Cyclical 16.01% Industrials 15.27% Health Care 4.44% Communication Services 4.06% Real Estate 2.81% Basic Materials 2% Utility 0.24% Financial Services 0.09% Asset Allocation
Asset Class Value Cash 31.18% Equity 68.82% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹3,078 Cr 3,600,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹2,960 Cr 5,250,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL8% ₹2,437 Cr 43,490,250 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹1,498 Cr 2,500,000 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA4% ₹1,236 Cr 6,750,000
↑ 250,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON4% ₹1,227 Cr 835,200
↑ 100,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | TRENT4% ₹1,210 Cr 2,143,194
↑ 7,450 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433964% ₹1,149 Cr 12,900,814
↑ 512,314 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹1,122 Cr 9,969,361 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI3% ₹993 Cr 2,750,000
↑ 50,000 2. LIC MF Infrastructure Fund
CAGR/Annualized
return of 9.8% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (01 Jul 25) ₹50.7897 ↑ 0.01 (0.02 %) Net Assets (Cr) ₹1,005 on 31 May 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.2 Information Ratio 0.54 Alpha Ratio 6.66 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,983 30 Jun 22 ₹17,801 30 Jun 23 ₹22,663 30 Jun 24 ₹41,985 30 Jun 25 ₹42,989 Returns for LIC MF Infrastructure Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 3.3% 3 Month 17.2% 6 Month -1.8% 1 Year 0.5% 3 Year 34.2% 5 Year 33.5% 10 Year 15 Year Since launch 9.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.7 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for LIC MF Infrastructure Fund as on 31 May 25
Equity Sector Allocation
Sector Value Industrials 51.57% Basic Materials 9.67% Consumer Cyclical 7.9% Utility 6.15% Financial Services 5.44% Real Estate 2.87% Communication Services 2.32% Technology 2.25% Health Care 0.42% Energy 0.4% Asset Allocation
Asset Class Value Cash 10.86% Equity 89.14% Top Securities Holdings / Portfolio
Name Holding Value Quantity Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹44 Cr 94,287 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹39 Cr 452,572
↑ 44,445 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | TATAPOWER3% ₹28 Cr 724,927 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹26 Cr 624,435
↑ 87,219 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | BHEL2% ₹24 Cr 913,126
↓ -149,073 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER2% ₹23 Cr 305,924
↓ -26,125 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD2% ₹23 Cr 571,332 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND2% ₹22 Cr 67,407
↑ 559 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹22 Cr 96,061
↓ -30,853 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 397,031
↓ -79,438 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized
return of 17.4% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (01 Jul 25) ₹53.3884 ↓ -0.05 (-0.10 %) Net Assets (Cr) ₹4,360 on 31 May 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.44 Information Ratio 0.98 Alpha Ratio 7.68 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,667 30 Jun 22 ₹14,668 30 Jun 23 ₹19,681 30 Jun 24 ₹31,051 30 Jun 25 ₹34,307 Returns for Motilal Oswal Long Term Equity Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 3% 3 Month 18.9% 6 Month -4.7% 1 Year 9.8% 3 Year 32.3% 5 Year 27.9% 10 Year 15 Year Since launch 17.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.47 Yr. Rakesh Shetty 22 Nov 22 2.53 Yr. Atul Mehra 1 Oct 24 0.67 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 May 25
Equity Sector Allocation
Sector Value Industrials 37.3% Consumer Cyclical 20.59% Financial Services 17.43% Technology 8.6% Real Estate 6.27% Basic Materials 5.67% Health Care 2.96% Asset Allocation
Asset Class Value Cash 1.18% Equity 98.82% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | TRENT6% ₹240 Cr 425,260 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433205% ₹236 Cr 9,923,692 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL5% ₹213 Cr 1,056,315 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹178 Cr 297,751 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹177 Cr 24,702,337 Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | 5390834% ₹159 Cr 8,173,777 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹156 Cr 240,350 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX4% ₹155 Cr 235,083 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹155 Cr 1,055,205 Bharat Electronics Ltd (Industrials)
Equity, Since 30 Apr 24 | BEL3% ₹152 Cr 3,950,000 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized
return of 18% since its launch. Ranked 5 in Multi Cap
category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (01 Jul 25) ₹63.4987 ↓ -0.04 (-0.06 %) Net Assets (Cr) ₹13,023 on 31 May 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.6 Information Ratio 0.67 Alpha Ratio 9.7 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹14,465 30 Jun 22 ₹12,910 30 Jun 23 ₹15,538 30 Jun 24 ₹24,143 30 Jun 25 ₹27,563 Returns for Motilal Oswal Multicap 35 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 5.9% 3 Month 11.4% 6 Month -0.5% 1 Year 14.2% 3 Year 28.8% 5 Year 22.5% 10 Year 15 Year Since launch 18% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.67 Yr. Niket Shah 1 Jul 22 2.92 Yr. Rakesh Shetty 22 Nov 22 2.53 Yr. Atul Mehra 1 Oct 24 0.67 Yr. Sunil Sawant 1 Jul 24 0.92 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 May 25
Equity Sector Allocation
Sector Value Technology 22.43% Industrials 18.22% Consumer Cyclical 17.08% Financial Services 8.53% Communication Services 8.52% Health Care 1.73% Consumer Defensive 0.54% Asset Allocation
Asset Class Value Cash 23.56% Equity 76.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE11% ₹1,389 Cr 1,625,000
↓ -100,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT10% ₹1,240 Cr 2,200,000 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB9% ₹1,164 Cr 1,942,305
↓ -57,570 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL8% ₹1,009 Cr 18,000,000
↑ 114,380 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | CGPOWER6% ₹841 Cr 12,250,000
↑ 175,830 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | TRENT6% ₹787 Cr 1,394,889 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN6% ₹720 Cr 4,500,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹701 Cr 4,999,500 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 May 25 | 5433203% ₹413 Cr 17,331,906
↑ 17,331,906 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 25 | BHARTIARTL3% ₹409 Cr 2,200,826
↑ 2,200,826 5. Invesco India Mid Cap Fund
CAGR/Annualized
return of 17.3% since its launch. Ranked 38 in Mid Cap
category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (01 Jul 25) ₹181.14 ↓ -0.14 (-0.08 %) Net Assets (Cr) ₹6,641 on 31 May 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.69 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,589 30 Jun 22 ₹16,322 30 Jun 23 ₹21,366 30 Jun 24 ₹33,031 30 Jun 25 ₹38,743 Returns for Invesco India Mid Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 7.1% 3 Month 18.5% 6 Month 5.1% 1 Year 17.3% 3 Year 33.4% 5 Year 31.1% 10 Year 15 Year Since launch 17.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.56 Yr. Amit Ganatra 1 Sep 23 1.75 Yr. Data below for Invesco India Mid Cap Fund as on 31 May 25
Equity Sector Allocation
Sector Value Financial Services 27.03% Health Care 17.76% Consumer Cyclical 15.55% Industrials 11.63% Technology 9.53% Real Estate 7.96% Basic Materials 7.71% Communication Services 1.94% Asset Allocation
Asset Class Value Cash 0.89% Equity 99.11% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE6% ₹406 Cr 1,519,233 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹289 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE4% ₹278 Cr 1,893,617 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | MFSL4% ₹270 Cr 1,798,532
↑ 114,429 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹258 Cr 12,745,942
↑ 239,160 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹253 Cr 2,246,434 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | TRENT4% ₹249 Cr 441,151 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹237 Cr 431,234 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON3% ₹228 Cr 155,335 HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Jan 25 | HDFCAMC3% ₹210 Cr 439,084 6. UTI Healthcare Fund
CAGR/Annualized
return of 15% since its launch. Ranked 40 in Sectoral
category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (01 Jul 25) ₹284.954 ↓ -1.14 (-0.40 %) Net Assets (Cr) ₹1,062 on 31 May 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.83 Information Ratio -0.11 Alpha Ratio 0.87 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,774 30 Jun 22 ₹13,373 30 Jun 23 ₹15,783 30 Jun 24 ₹22,500 30 Jun 25 ₹27,347 Returns for UTI Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 3.4% 3 Month 6.7% 6 Month -2.4% 1 Year 21.5% 3 Year 26.9% 5 Year 22.3% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Data below for UTI Healthcare Fund as on 31 May 25
Equity Sector Allocation
Sector Value Health Care 96.34% Basic Materials 0.99% Asset Allocation
Asset Class Value Cash 2.67% Equity 97.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹111 Cr 661,016
↓ -11,873 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹59 Cr 400,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹50 Cr 396,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹46 Cr 80,283
↑ 520 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM4% ₹43 Cr 172,829 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹40 Cr 275,250 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹37 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS3% ₹33 Cr 465,000 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS3% ₹32 Cr 204,451
↓ -8,479 7. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 15.6% since its launch. Ranked 34 in Sectoral
category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (30 Jun 25) ₹432.453 ↑ 4.56 (1.06 %) Net Assets (Cr) ₹3,689 on 31 May 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.97 Information Ratio 0.52 Alpha Ratio 2.81 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,902 30 Jun 22 ₹13,774 30 Jun 23 ₹17,755 30 Jun 24 ₹24,634 30 Jun 25 ₹29,799 Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 3.4% 3 Month 5.2% 6 Month -1% 1 Year 21% 3 Year 29.3% 5 Year 24.4% 10 Year 15 Year Since launch 15.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 May 25
Equity Sector Allocation
Sector Value Health Care 90.06% Basic Materials 6.02% Asset Allocation
Asset Class Value Cash 3.92% Equity 96.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹470 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹273 Cr 412,222
↑ 12,222 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹236 Cr 2,100,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹178 Cr 300,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA5% ₹176 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN4% ₹164 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹123 Cr 1,800,000
↓ -234,372 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS3% ₹119 Cr 1,680,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹118 Cr 1,000,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized
return of 12.3% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (01 Jul 25) ₹30.0908 ↓ -0.11 (-0.35 %) Net Assets (Cr) ₹1,232 on 31 May 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.54 Information Ratio 0.74 Alpha Ratio 1.9 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,403 30 Jun 22 ₹13,787 30 Jun 23 ₹16,370 30 Jun 24 ₹23,471 30 Jun 25 ₹27,032 Returns for TATA India Pharma & Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 2.9% 3 Month 6.2% 6 Month -5.6% 1 Year 14.5% 3 Year 24.7% 5 Year 22.1% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.23 Yr. Rajat Srivastava 16 Sep 24 0.71 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 May 25
Equity Sector Allocation
Sector Value Health Care 88.47% Basic Materials 2.37% Asset Allocation
Asset Class Value Cash 9.16% Equity 90.84% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹143 Cr 854,300 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹77 Cr 111,255
↑ 10,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA6% ₹72 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹71 Cr 615,100 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB6% ₹69 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS5% ₹60 Cr 855,100 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN5% ₹59 Cr 303,240 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹54 Cr 956,991 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA3% ₹40 Cr 274,871 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY3% ₹39 Cr 311,555 9. IDBI Small Cap Fund
CAGR/Annualized
return of 14.9% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (01 Jul 25) ₹30.585 ↑ 0.00 (0.01 %) Net Assets (Cr) ₹576 on 31 May 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 0.05 Information Ratio -0.61 Alpha Ratio -3.19 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹19,231 30 Jun 22 ₹20,995 30 Jun 23 ₹27,082 30 Jun 24 ₹41,784 30 Jun 25 ₹40,559 Returns for IDBI Small Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 3.1% 3 Month 10% 6 Month -10.9% 1 Year -4.6% 3 Year 24.5% 5 Year 32.2% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.92 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for IDBI Small Cap Fund as on 31 May 25
Equity Sector Allocation
Sector Value Industrials 29.89% Consumer Cyclical 17.72% Basic Materials 13.84% Consumer Defensive 8.73% Utility 6.59% Financial Services 6.47% Technology 6.16% Health Care 3.85% Communication Services 2.83% Real Estate 0.41% Asset Allocation
Asset Class Value Cash 3.51% Equity 96.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹18 Cr 390,711
↓ -10,540 JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹17 Cr 2,506,932 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹16 Cr 668,754
↓ -42,908 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419743% ₹16 Cr 109,106
↓ -6,221 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹16 Cr 270,441 Enviro Infra Engineers Ltd (Industrials)
Equity, Since 30 Nov 24 | EIEL2% ₹13 Cr 553,566
↑ 44,921 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL2% ₹13 Cr 337,832 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL2% ₹13 Cr 326,140 Hindustan Foods Ltd (Industrials)
Equity, Since 31 Jul 24 | 5191262% ₹13 Cr 236,195
↑ 16,141 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹13 Cr 1,130,075
↑ 45,798 10. L&T Midcap Fund
CAGR/Annualized
return of 19.3% since its launch. Ranked 5 in Mid Cap
category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (01 Jul 25) ₹395.818 ↓ -0.11 (-0.03 %) Net Assets (Cr) ₹11,470 on 31 May 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.2 Information Ratio -0.25 Alpha Ratio -0.69 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹16,076 30 Jun 22 ₹15,586 30 Jun 23 ₹19,174 30 Jun 24 ₹31,208 30 Jun 25 ₹33,257 Returns for L&T Midcap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Jul 25 Duration Returns 1 Month 5.8% 3 Month 16.9% 6 Month -3% 1 Year 6.6% 3 Year 28.7% 5 Year 27.2% 10 Year 15 Year Since launch 19.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Cheenu Gupta 26 Nov 22 2.51 Yr. Sonal Gupta 1 Oct 23 1.67 Yr. Data below for L&T Midcap Fund as on 31 May 25
Equity Sector Allocation
Sector Value Industrials 22.95% Financial Services 22.02% Consumer Cyclical 20.17% Health Care 12.43% Technology 10.13% Consumer Defensive 4.08% Basic Materials 2.61% Communication Services 1.89% Utility 1.64% Real Estate 0.58% Asset Allocation
Asset Class Value Cash 1.51% Equity 98.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE5% ₹533 Cr 1,994,300
↓ -406,600 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH4% ₹490 Cr 4,355,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹448 Cr 304,800 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹419 Cr 17,596,500 Jubilant Foodworks Ltd (Consumer Cyclical)
Equity, Since 31 Mar 25 | 5331554% ₹410 Cr 6,248,000
↑ 3,530,506 GE Vernova T&D India Ltd (Industrials)
Equity, Since 30 Sep 24 | 5222753% ₹401 Cr 1,790,330 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | TRENT3% ₹385 Cr 681,700 Nippon Life India Asset Management Ltd Ordinary Shares (Financial Services)
Equity, Since 30 Apr 24 | NAM-INDIA3% ₹384 Cr 5,181,300
↑ 1,674,700 Godfrey Phillips India Ltd (Consumer Defensive)
Equity, Since 31 Jan 19 | GODFRYPHLP3% ₹326 Cr 374,885 Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT3% ₹323 Cr 573,700
↓ -153,400